TITAN-RX

TM

TITAN-RX is our novel proprietary multi-modal in vivo imaging approach at Durametrix which enables simultaneous whole-body detection of on-target cytotoxic efficacy and off-target cytotoxic tissue damage in an individualized, systemic, population-based, and dynamic manner! This technology facilitates a multitude of data that enables a much more comprehensive understanding of drug safety and potential tissue damage in the convenience of an easy to read and understandable report complete with observational and quantitative data, all while saving time and money!

 

Scroll Down To Learn More

See How TITAN-RX   Compares With Traditional Approaches....

TM

TitanTAblev2_edited.png

Scroll Down To Learn More

TM

Potential Roles Of TITAN-RX   Imaging Technology
Along The Cascade Of Drug Discovery.

Picture2TITAN.png

TITAN-RX imaging technology is cost-effective, dynamic, systemic, near-real time, and provides valuable information at multiple stages in the process of drug discovery which helps characterize candidates of interest and streamline decision making by identifying efficacious and safe candidates for clinical translation while eliminating drug candidates that have excessive adverse off-target side effects. This technology can be used as stand-alone, or complementary to conventional toxicology assays and studies.